Reaction

Renal Atrophy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,235 reports · 36 co-occurring drugs

As of the last recalculation, Renal Atrophy appears in 1,235 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is PYRAZINAMIDE (PRR 23.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Pyrazinamide	13	23.6	23.6
Lansoprazole	203	22.8	22.8
Epoetin Alfa	15	21.6	21.6
Eplerenone	14	18.6	18.6
Isosorbide Dinitrate	21	18.4	18.4
Esomeprazole	63	18.0	18.0
Atazanavir	15	17.8	17.8
Sodium Bicarbonate	24	17.7	17.7
Sodium Bicarbonate Injection,	24	17.7	17.7
Rifampicin	10	16.8	16.8
Esomeprazole Magnesium Capsule, Delayed Release	14	16.4	16.5
Esomeprazole Magnesium Delayed Release Capsules	14	16.4	16.5
Esomeprazole Magnesium Dihydrate	14	16.4	16.4
Amphotericin B	12	16.3	16.3
Abacavir Sulfate	9	15.7	15.7
Febuxostat Tablets 40 Mg	9	15.0	15.0
Febuxostat Tablets 80 Mg	9	15.0	15.0
Isoniazid	14	14.7	14.7
Sirolimus	11	13.9	13.9
Tenofovir Disoproxil Fumarate Tablets	7	13.7	13.7
Clarithromycin	27	13.5	13.5
Tenofovir Disoproxil Fumarate	25	13.0	13.0
Torsemide	25	13.0	13.0
Esomeprazole Magnesium	155	12.6	12.6
Erythropoietin	15	12.4	12.4
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	6	11.3	11.3
Dapagliflozin	19	10.3	10.3
Dexlansoprazole	25	10.3	10.3
Lamivudine	18	9.9	10.0
Bleomycin Sulfate	6	9.8	9.8
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	5	8.4	8.4
Darbepoetin Alfa	24	7.6	7.6
Emtricitabine And Tenofovir Disoproxil Fumarate	20	7.5	7.5
Emtricitabine And Tenofovir Alafenamide	4	6.0	6.0
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	5	4.7	4.7
Aflibercept	8	4.3	4.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.